Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation of CD38-Targeted Molecular Imaging Probes in Multiple Myeloma

NCT07782944 is registered in ClinicalTrials.gov with Guilin Medical University, China as lead sponsor.

NCT NCT07782944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07782944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation of CD38-Targeted Molecular Imaging Probes in Multiple Myeloma
Lead sponsor
Guilin Medical University, China
Phase
Not applicable
Overall status
Recruiting
Start date
July 7, 2026
Completion date
December 31, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma (mm), lymphoma, large b-cell, diffuse (dlbcl), lymphoma